Complete the Contact Request Form and a Registry team member will contact you.
Are you pregnant and diagnosed with narcolepsy or obstructive sleep apnea (OSA)?
ORHave you taken SUNOSI® (solriamfetol), another wake-promoting medication, or stimulants during your pregnancy?
Excessive daytime sleepiness due to narcolepsy or OSA can be debilitating. Help future pregnant women, doctors and researchers understand the safety of medications that can help you manage your condition.
Would you like to participate? Contact the Registry today.
Complete the Contact Request Form and a Registry team member will contact you.
Email the Registry team with your contact information at: sunosipregnancyregistry@ppd.com
Call the registry team toll-free at 1-877-283-6220 (hours of operation 8.30 am – 5.00 pm ET Monday-Friday)
SUNOSI is a prescription medicine that is used to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea (OSA).
Future pregnant women, doctors and researchers can benefit from the information you provide to the registry. Most importantly, it may help other pregnant women like yourself who suffer from narcolepsy or OSA.
If you are eligible and would like to participate, you will be asked to:
You and your healthcare providers will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms, via the free registry app or website portal, or via short phone interviews with one of the registry staff members. Only information normally documented in your medical record will be collected.
If you participate, there will be:
You and your healthcare provider(s) will receive compensation for providing data to the registry.
You will receive $50 for you participation in the registry:
If you are eligible and would like to participate, you will be asked to provide basic information about yourself (e.g., race, ethnicity, education, height, and weight) to the registry at enrollment.